Metraipolis › archive › dc_d23930a822ac

Alzheimer's disease: from molecular pathways to therapies — Europe PMC PMID:41925951

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41925951
DOI
10.1186/s43556-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-03T10:08:15.490Z
SHA-256 of the archived text
8a0f2c180d22a73835fb0345622de33e84b011caf18ff411a1be6489e2b5997c
Stable URL of this page
https://metraipolis.com/documento/dc_d23930a822ac

How to cite

Alzheimer's disease: from molecular pathways to therapies — Europe PMC PMID:41925951 — Europe PMC (en), https://europepmc.org/article/MED/41925951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d23930a822ac (Metraipolis archive dc_d23930a822ac, sha256 8a0f2c180d22a73835fb0345622de33e84b011caf18ff411a1be6489e2b5997c)
BibTeX
@misc{dcd23930a822ac,
  title = {Alzheimer's disease: from molecular pathways to therapies — Europe PMC PMID:41925951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41925951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d23930a822ac; sha256 8a0f2c180d22a73835fb0345622de33e84b011caf18ff411a1be6489e2b5997c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41925951. Agents can read the archived copy with the MCP tool read_document.